Skip to main content
OpenTrials

Clinical trial condition

Leukemia, Myeloid

Explore clinical trials studying Leukemia, Myeloid. Study availability and eligibility vary by location and protocol.

3,106 public trials 617 recruiting studies
Refine in advanced search Browse all conditions

Leukemia, Myeloid trial results

Completed

Phase 3 Randomized, Open-Label Study of Guadecitabine vs Treatment Choice in Previously Treated Acute Myeloid Leukemia

NCT02920008

Conditions
Acute Myeloid Leukemia, Hematologic Diseases, Hemic and Lymphatic Diseases, +5 more
Locations
  • University of Southern California Los Angeles, California, United States
  • The University of Chicago Medical Center Chicago, Illinois, United States
  • Franciscan Research Center Indianapolis, Indiana, United States
  • John Theurer Cancer Center at Hackensack University Medical Center Hackensack, New Jersey, United States
View all 95 locations
View Trial Details
Completed

Guadecitabine (SGI-110) vs Treatment Choice in Adults With MDS or CMML Previously Treated With HMAs

NCT02907359

Conditions
Bone Marrow Diseases, Chronic Disease, Disease Attributes, +11 more
Locations
  • City of Hope Duarte, California, United States
  • Desert Hematology Oncology Medical Group, Inc. Rancho Mirage, California, United States
  • Cancer Specialists of North Florida Fleming Island, Florida, United States
  • Mount Sinai Medical Center Miami Beach, Florida, United States
View all 112 locations
View Trial Details
Completed

SGI-110 in Adults With Untreated Acute Myeloid Leukemia (AML), Not Considered Candidates for Intensive Remission Induction

NCT02348489

Conditions
Hematologic Diseases, Hemic and Lymphatic Diseases, Leukemia, +4 more
Locations
  • Mayo Clinic Cancer Center Scottsdale, Arizona, United States
  • Scripps Cancer Center La Jolla, California, United States
  • University of Southern California Los Angeles, California, United States
  • University of Chicago Chicago, Illinois, United States
View all 135 locations
View Trial Details
Completed

Study of ASTX727 vs IV Decitabine in Participants With MDS, CMML, and AML

NCT03306264

Conditions
Acute Myeloid Leukemia, Bone Marrow Diseases, Chronic Disease, +14 more
Locations
  • Pinnacle Research Group Anniston, Alabama, United States
  • Mayo Clinic Arizona Phoenix, Arizona, United States
  • Arizona Clinical Research Center Tucson, Arizona, United States
  • Compassionate Cancer Care Research Group Fountain Valley, California, United States
View all 84 locations
View Trial Details
Completed

A Study of Revumenib in Combination With Chemotherapy in Participants With R/R Acute Leukemia

NCT05326516

Conditions
Acute Lymphoblastic Leukemia, Acute Lymphocytic Leukemia, Acute Myeloid Leukemia, +17 more
Locations
  • University of California, San Francisco (UCSF) Benioff Children's Hospital San Francisco, California, United States
  • Dana-Farber Cancer Institute Boston, Massachusetts, United States
  • Children's Mercy Hospital Kansas City, Missouri, United States
  • Washington University School of Medicine St Louis, Missouri, United States
View Trial Details
Completed

Quizartinib With Standard of Care Chemotherapy and as Continuation Therapy in Patients With Newly Diagnosed FLT3-ITD (+) Acute Myeloid Leukemia (AML)

NCT02668653

Conditions
Acute Myeloid Leukemia, Hematologic Diseases, Hemic and Lymphatic Diseases, +5 more
Locations
  • University of Florida (UF) Health Shands Hospital Gainesville, Florida, United States
  • The University of Chicago Medical Center Chicago, Illinois, United States
  • Franciscan St. Francis Health Indianapolis Indianapolis, Indiana, United States
  • University of Kentucky Chandler Medical Center Lexington, Kentucky, United States
View all 244 locations
View Trial Details

Related conditions